Notice of Qingdao Weilan Biological Co., Ltd. on convening the first extraordinary shareholders' meeting in 2026
Securities code: 603739 Securities abbreviation: Weilan Biotechnology Announcement number: 2026-005 Qingdao Weilan Biotechnology Co., Ltd.
Notice on convening the first extraordinary shareholders' meeting in 2026
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Date of shareholders’ meeting: March 6, 2026
The online voting system adopted for this shareholders’ meeting: Shanghai Stock Exchange Shareholders’ Meeting Online Voting System
1. Basic information on convening the meeting
(1) Type and session of shareholders’ meeting
The first extraordinary shareholders' meeting in 2026
(2) Convener of shareholders’ meeting: Board of Directors
(3) Voting method: The voting method used in this shareholders’ meeting is a combination of on-site voting and online voting.
way
(4) Date, time and place of on-site meeting
Date and time of convening: March 6, 2026 14:30
Venue: Multimedia Conference, Building B, Weilan Biological Innovation Park, No. 596-1, Jiushui East Road, Laoshan District, Qingdao City
room
(5) Online voting system, start and end dates and voting time.
Online voting system: Shanghai Stock Exchange Shareholders Meeting online voting system
Online voting starts and ends on March 6, 2026
Until March 6, 2026
Using the Shanghai Stock Exchange's online voting system, the voting time through the trading system voting platform is the trading time period on the day the shareholders' meeting is held, that is, 9:15-9:25, 9:30-11:30, 13:00-15:00; the voting time through the Internet voting platform is 9:15-15:00 on the day the shareholders' meeting is held.
(6) Voting procedures for margin trading, securities lending, refinancing, agreed repurchase business accounts and Shanghai-Hong Kong Stock Connect investors
Voting involving accounts related to margin financing and securities lending, refinancing business, agreed repurchase business, and Shanghai-Hong Kong Stock Connect investors shall be implemented in accordance with the "Shanghai Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations" and other relevant regulations.
(7) Involving public solicitation of shareholder voting rights
None
2. Matters to be considered at the meeting
The resolutions to be reviewed and the types of voting shareholders at this shareholders’ meeting
Voting shareholder type serial number Proposal name
Non-cumulative voting resolution for A-share shareholders
"About the Acquisition of Aidimeng Weilan Biotechnology (Shandong) by a Wholly-Owned Subsidiary"
1 √
Proposal on 50% Equity Interest of East) Co., Ltd.
- The time and disclosure media of each proposal
The above proposal has been reviewed and approved at the 23rd meeting of the fifth session of the Board of Directors of the company. Relevant announcements were published in "China Securities Journal", "Shanghai Securities News", "Securities Times" and "Securities News" on February 11, 2026.
Daily" and Shanghai Stock Exchange website (www.sse.com.cn)
Special resolutions: None
Proposal to count votes separately for small and medium investors: 1
Proposals involving related shareholders’ avoidance of voting: None
Name of related shareholders who should avoid voting: None
- Proposals involving preference shareholders’ participation in voting: None
3. Things to note when voting at the shareholders’ meeting
(1) The shareholders of the Company who exercise their voting rights through the Shanghai Stock Exchange Shareholders Meeting online voting system can either log in to the trading system voting platform (through the trading terminal of the securities company designated for trading) to vote, or log in to the Internet voting platform (website: vote.sseinfo.com) to vote. When logging into the Internet voting platform to vote for the first time, investors need to complete shareholder identity authentication. For specific operations please
See the Internet voting platform website description.
(2) The same voting right is voted repeatedly through on-site, online voting platform of the Exchange or other methods,
The results of the first vote shall prevail.
(3) For a shareholder holding multiple shareholder accounts, the number of exercisable voting rights is the total number of common shares of the same category and preference shares of the same variety held by all shareholder accounts under his or her name.
Shareholders holding multiple shareholder accounts who participate in online voting at the shareholders' meeting through the Exchange's online voting system can participate through any of their shareholder accounts. After the voting, it shall be deemed that all ordinary shares of the same category and preferred shares of the same variety under all shareholder accounts have voted with the same opinion.
If a shareholder holding multiple shareholder accounts votes repeatedly through multiple shareholder accounts, the voting opinions of the same class of ordinary shares and the same type of preferred stocks under all shareholder accounts shall be based on the first voting results of each class and type of stocks respectively.
(4) Shareholders must vote on all proposals before they can be submitted.
4. Participants at the meeting
(1) Shareholders of the company who are registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. at the market close on the afternoon of the equity registration day have the right to attend the shareholders’ meeting (see the table below for details), and may entrust a proxy in writing to attend the meeting and participate in voting. The agent does not have to be a shareholder of the company.
Share class Stock code Stock abbreviation Equity registration date
A shares 603739 Azure Biotech 2026/2/27
(2) Directors and senior managers of the company.
(3) Lawyers hired by the company.
(4) Other personnel
5. Meeting registration method
Registration time: 9:00-12:00 and 14:00-14:30 on March 6, 2026.
Registration method: If the legal representative of the company's legal person shareholder attends the meeting, he or she should present a copy of the business license (with an official seal), his or her ID card, a valid certificate that proves his qualifications as a legal representative, and a shareholding certificate; if an agent is authorized to attend the meeting, the agent should present a copy of the business license (with an official seal), this certificate. Personal ID card, written power of attorney and shareholding certificate issued by the legal representative of the legal person shareholder unit in accordance with the law; natural person shareholders who attend the meeting in person should present their ID card, securities account card and shareholding certificate; those who entrust an agent to attend the meeting should present the agent's ID card, principal's ID card, power of attorney and shareholding certificate.
Registration method: direct registration. Foreign shareholders can register by sending scanned copies by letter or email. The company does not accept telephone registration.
Registration location: Multimedia Conference Room, Building B, Weilan Biological Innovation Park, No. 596-1, Jiushui East Road, Laoshan District, Qingdao City.
6. Other matters
Mailing address: Weilan Bio Innovation Park, No. 596-1, Jiushui East Road, Laoshan District, Qingdao City; Postal code: 266100; please indicate the words "Shareholders Meeting" on the envelope of the letter.
Contact person: Jiang Yong
Contact number: 0532-88978071, email: [email protected]
This shareholders’ meeting lasts for half a day. Participants must bear their own transportation, food and accommodation expenses.
Announcement is hereby made.
Board of Directors of Qingdao Weilan Biological Co., Ltd.
February 11, 2026 Attachment 1: Power of Attorney
Reporting documents
Board resolution proposing to convene this shareholders’ meeting
Attachment 1: Power of attorney
Power of attorney
Qingdao Weilan Biological Co., Ltd.:
I hereby authorize Mr. (Ms.) to represent the unit (or myself) at your company’s first extraordinary shareholders’ meeting of 2026 to be held on March 6, 2026, and to exercise voting rights on your behalf.
Number of common shares held by the client:
Number of preferred shares held by the client:
Client shareholder account number:
Serial number Name of the non-cumulative voting motion Agree Oppose Abstain "About the acquisition of Aidimeng Weilan Biotechnology by a wholly-owned subsidiary
Proposal on 50% Equity Interest of (Shandong) Co., Ltd."
Signature (stamped) of the principal: Signature of the trustee:
Trustee’s ID number: Trustee’s ID number:
Date of entrustment: Year Month Day Remarks:
The client should choose one of the "agree", "objection" or "abstain" intentions in the power of attorney and tick "√". If the client does not give specific instructions in this power of attorney, the trustee has the right to vote according to his own wishes.